A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

about

A novel gene-pair signature for relapse-free survival prediction in colon cancer

P2860

Q57484422-75792FF2-517E-4A33-AFE8-B4C9D2B1F6AE

P2860

A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

Item

http://www.wikidata.org/entity/Q49607836

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

@en

A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

@nl

type

Item

label

A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

@en

A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

@nl

prefLabel

A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

@en

A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

@nl

P1476

A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

@en

P2093

Guoxiang Cai

http://www.w3.org/2001/XMLSchema#string

Long Zhang

http://www.w3.org/2001/XMLSchema#string

Qingguo Li

http://www.w3.org/2001/XMLSchema#string

Shaobo Mo

http://www.w3.org/2001/XMLSchema#string

Weixing Dai

http://www.w3.org/2001/XMLSchema#string

Yang Feng

http://www.w3.org/2001/XMLSchema#string

Yaqi Li

http://www.w3.org/2001/XMLSchema#string

Ye Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer

THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL

Cancer statistics, 2016

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis.

The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression.

Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer.

Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials.

Oncotype DX tumor gene expression profiling in stage II colon cancer. Application: prognostic, risk prediction.

P304

463-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1878-0261.12175

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29377588

http://www.w3.org/2001/XMLSchema#string

P932

5891048

http://www.w3.org/2001/XMLSchema#string

A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

about

P2860

P2860

A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932